DFCM
HUMA icon

Dark Forest Capital Management’s Humacyte HUMA Stock Holding History

Dark Forest Capital Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-42,875
Closed -$217K – 1323
2024
Q4 		$217K Buy
42,875
+12,905
+43% +$63.9K 0.03% 798
2024
Q3 		$163K Buy
+29,970
New +$198K 0.02% 897

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Dark Forest Capital Management's HUMA Position: Q1 2025 in Review

Dark Forest Capital Management sold out of Humacyte (HUMA) in Q1 2025, closing a stake of 42,875 shares — an estimated $217K sold.

Dark Forest Capital Management first reported a position in HUMA in Q3 2024 and held it in 2 quarters. The position peaked at $217K in Q4 2024. 168 funds tracked by Wall St. Rank hold HUMA as of Q1 2025.

  • Dark Forest Capital Management reported no remaining Humacyte position as of Q1 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 42,875 Humacyte shares in Q1 2025, an estimated $217K.
  • Dark Forest Capital Management first reported a position in Humacyte in Q3 2024 and held it in 2 quarters.
  • Dark Forest Capital Management's Humacyte position peaked at $217K in Q4 2024.
  • 168 funds tracked by Wall St. Rank held Humacyte as of Q1 2025.

Based on Dark Forest Capital Management's 13F filing for Q1 2025, filed 15 May 2025.